Gosset Ownership
Private
Employees
~6
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Aneira Pharma General Information
Aneira Pharma is developing ANR-001.1, a novel topical formulation for hair growth that has shown promising results in promoting thicker, darker hair growth in both men and women. The company has two clinical trials: a Phase 1 study of safety and pharmacokinetics in male subjects with androgenetic alopecia, and an Early Phase 1 study evaluating the safety and efficacy of a Latanoprost/Minoxidil formulation for eyebrow hypotrichosis[2][5].
Contact Information
Primary Industry
Biotech
Corporate Office
San Diego, California
United States
United States
Drug Pipeline
ANR-001
Pre-clinicalKey Partnerships
Aneira Pharma Funding
No funding data available
To view Aneira Pharma's complete valuation and funding history, request access »